文献速递产科母胎医学

剖宫产绒毛膜羊膜炎患者术前用头孢唑林较克林霉素或甲硝唑降低产后感染

Preoperative cefazolin rather than clindamycin or metronidazole is associated with lower postpartum infection among women with chorioamnionitis delivering by cesarean delivery.
PubMed 文献 · Am J Obstet Gynecol MFM · 2019-11-22

本研究为MFMU剖宫产注册数据的二次分析,纳入1105例因推测绒毛膜羊膜炎行剖宫产的产妇,均接受青霉素或氨苄西林联合庆大霉素基础方案。比较额外使用头孢唑林 versus 克林霉素或甲硝唑,发现头孢唑林组产后感染复合结局风险更低(aOR 0.49,95%CI 0.26-0.90),主要驱动手术部位感染减少。

要点

  • 剖宫产绒毛膜羊膜炎产妇中,头孢唑林较克林霉素或甲硝唑降低产后感染复合结局。
  • 该获益主要来自手术部位感染减少(aOR 0.11,95%CI 0.01-0.92),对子宫内膜炎无显著影响。
  • 研究为观察性二次分析,需随机试验验证。

核心结论

  • 在因绒毛膜羊膜炎行剖宫产的产妇中,额外使用头孢唑林较克林霉素或甲硝唑降低产后感染风险,主要减少手术部位感染。

研究设计与样本

  • 基于MFMU剖宫产注册数据的二次分析,纳入1105例推测绒毛膜羊膜炎(产时发热>100.4°F且接受产时抗生素)行剖宫产的产妇。
  • 所有产妇均接受青霉素或氨苄西林联合庆大霉素基础方案,比较额外头孢唑林(22.0%,n=244)与克林霉素或甲硝唑(77.9%,n=861)。
  • 采用多变量logistic回归调整年龄、产次、种族/民族、保险、分娩时BMI、吸烟、孕前糖尿病、ASA分级、剖宫产前试产及产后抗生素。

主要发现

  • 产后感染复合结局(子宫内膜炎和手术部位感染)发生率为9.5%,其中子宫内膜炎占80.9%,手术部位感染占20.9%(非互斥)。
  • 头孢唑林组较克林霉素或甲硝唑组产后感染复合结局的调整OR为0.49(95%CI 0.26-0.90)。
  • restricted to手术部位感染时,调整OR为0.11(95%CI 0.01-0.92);对子宫内膜炎无显著关联。
  • 倾向性评分分析得到相似结果。

临床怎么用

  • 对于因绒毛膜羊膜炎行剖宫产的产妇,在青霉素或氨苄西林联合庆大霉素基础上,可考虑额外使用头孢唑林以降低手术部位感染风险。
  • 当前标准克林霉素或甲硝唑在预防手术部位感染方面可能不如头孢唑林,但需结合当地耐药谱和指南。

局限性

  • 为观察性二次分析,存在残余混杂可能。
  • 头孢唑林组样本量较小(n=244),事件数有限。
  • 推测绒毛膜羊膜炎定义基于产时发热和抗生素使用,可能存在错分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The optimal antibiotic regimen to prevent maternal postpartum infection among high-risk women treated for chorioamnionitis delivering by cesarean delivery remains to be defined. Emerging data suggest that cefazolin decreases the risk of cesarean surgical site infection. OBJECTIVE: To investigate whether intrapartum antibiotic therapy with cefazolin versus the current standard clindamycin or metronidazole decreases the risk of postpartum infectious morbidity among women delivering by cesarean delivery who were receiving a base regimen of ampicillin or penicillin with gentamicin for chorioamnionitis. MATERIALS AND METHODS: A secondary analysis from the Maternal-Fetal Medicine Units Network (MFMU) Cesarean Registry. We included women who delivered by cesarean delivery with presumptive chorioamnionitis (intrapartum fever >100.4°F and receipt of intrapartum antibiotics). All women received a base regimen of penicillin or ampicillin with gentamicin. We compared antibiotic therapy with cefazolin versus clindamycin or metronidazole. The primary outcome was a composite of postpartum maternal infection, including endometritis and surgical site infection. Multivariable logistic regression was used, adjusting for age, parity, race/ethnicity, insurance, body mass index at delivery, tobacco use, pregestational diabetes, American Society of Anesthesiologists classification, trial of labor prior to cesarean delivery, and postpartum antibiotics. RESULTS: Among 1105 women with presumptive chorioamnionitis who delivered by cesarean delivery, 22.0% (n = 244) received cefazolin and 77.9% (n = 861) received clindamycin or metronidazole. Most women were in labor prior to cesarean delivery (93.8%) and received postpartum antibiotics (88.4%). Almost one-tenth (9.5%) were diagnosed with a postpartum infection, most commonly endometritis (80.9%), followed by surgical site infection (20.9%) (not mutually exclusive). Women treated with cefazolin rather than clindamycin or metronidazole had lower odds of postpartum infectious morbidity (adjusted odds ratio, 0.49; 95% confidence interval, 0.26-0.90). This association held when the outcome was restricted to surgical site infection (adjusted odds ratio, 0.11; 95% confidence interval, 0.01-0.92) but not endometritis. Similar results were observed with propensity score analysis. CONCLUSION: Among women delivering by cesarean delivery who were treated for chorioamnionitis, additional antibiotic therapy with cefazolin decreased the risk of postpartum infection, primarily surgical site infection, compared to the current standard clindamycin or metronidazole.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Venkatesh KK, Hughes BL, Grotegut CA, et al. Preoperative cefazolin rather than clindamycin or metronidazole is associated with lower postpartum infection among women with chorioamnionitis delivering by cesarean delivery. Am J Obstet Gynecol MFM. 2019. PMID: 33345988. doi:10.1016/j.ajogmf.2019.100074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。